Oncolytic Viruses—Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer

by Anwen Howells, Giulia Marelli, Nicholas R. Lemoine, Nicholas R. Lemoine, Yaohe Wang, Yaohe Wang
Published 2017-09-01

Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer

by Giulia Marelli, Anwen Howells, Nicholas R. Lemoine, Nicholas R. Lemoine, Yaohe Wang, Yaohe Wang
Published 2018-04-01

Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles

by Mark S. Ferguson, Nicholas R. Lemoine, Yaohe Wang
Published 2012-01-01

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles

by Yaohe Wang, Han Hsi Wong, Nicholas R. Lemoine
Published 2010-01-01

A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma

by Zifang Zhang, Chunyang Zhang, Jinxin Miao, Zhizhong Wang, Zhimin Wang, Zhenguo Cheng, Pengju Wang, Louisa S. Chard Dunmall, Nicholas R. Lemoine, Yaohe Wang
Published 2020-11-01

Molecular analysis of precursor lesions in familial pancreatic cancer.

by Tatjana Crnogorac-Jurcevic, Claude Chelala, Sayka Barry, Tomohiko Harada, Vipul Bhakta, Sam Lattimore, Stipo Jurcevic, Mary Bronner, Nicholas R Lemoine, Teresa A Brentnall
Published 2013-01-01

Splice variants as novel targets in pancreatic ductal adenocarcinoma

by Jun Wang, Laurent Dumartin, Andrea Mafficini, Pinar Ulug, Ajanthah Sangaralingam, Namaa Audi Alamiry, Tomasz P. Radon, Roberto Salvia, Rita T. Lawlor, Nicholas R. Lemoine, Aldo Scarpa, Claude Chelala, Tatjana Crnogorac-Jurcevic
Published 2017-06-01

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

by Pengju Wang, Xiaozhu Li, Jiwei Wang, Dongling Gao, Yuenan Li, Haoze Li, Yongchao Chu, Zhongxian Zhang, Hongtao Liu, Guozhong Jiang, Zhenguo Cheng, Shengdian Wang, Jianzeng Dong, Baisui Feng, Louisa S. Chard, Nicholas R. Lemoine, Yaohe Wang
Published 2017-11-01

Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

by Pengju Wang, Xiaozhu Li, Jiwei Wang, Dongling Gao, Yuenan Li, Haoze Li, Yongchao Chu, Zhongxian Zhang, Hongtao Liu, Guozhong Jiang, Zhenguo Cheng, Shengdian Wang, Jianzeng Dong, Baisui Feng, Louisa S Chard, Nicholas R Lemoine, Yaohe Wang
Published 2018-01-01

Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression

by Silvia Ottaviani, Justin Stebbing, Adam E. Frampton, Sladjana Zagorac, Jonathan Krell, Alexander de Giorgio, Sara M. Trabulo, Van T. M. Nguyen, Luca Magnani, Hugang Feng, Elisa Giovannetti, Niccola Funel, Thomas M. Gress, Long R. Jiao, Ylenia Lombardo, Nicholas R. Lemoine, Christopher Heeschen, Leandro Castellano
Published 2019-08-01

TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression

by Silvia Ottaviani, Justin Stebbing, Adam E. Frampton, Sladjana Zagorac, Jonathan Krell, Alexander de Giorgio, Sara M. Trabulo, Van T. M. Nguyen, Luca Magnani, Hugang Feng, Elisa Giovannetti, Niccola Funel, Thomas M. Gress, Long R. Jiao, Ylenia Lombardo, Nicholas R. Lemoine, Christopher Heeschen, Leandro Castellano
Published 2018-05-01

A HIF–LIMD1 negative feedback mechanism mitigates the pro‐tumorigenic effects of hypoxia

by Daniel E Foxler, Katherine S Bridge, John G Foster, Paul Grevitt, Sean Curry, Kunal M Shah, Kathryn M Davidson, Ai Nagano, Emanuela Gadaleta, Hefin I Rhys, Paul T Kennedy, Miguel A Hermida, Ting‐Yu Chang, Peter E Shaw, Louise E Reynolds, Tristan R McKay, Hsei‐Wei Wang, Paulo S Ribeiro, Michael J Plevin, Dimitris Lagos, Nicholas R Lemoine, Prabhakar Rajan, Trevor A Graham, Claude Chelala, Kairbaan M Hodivala‐Dilke, Ian Spendlove, Tyson V Sharp
Published 2018-08-01